scholarly article | Q13442814 |
P2093 | author name string | Se Jin Jang | |
Dae Hyuk Moon | |||
Jong Jin Lee | |||
Seung Jin Lee | |||
Eun Jung Lee | |||
Jin-Sook Ryu | |||
Seog Young Kim | |||
Jeong Seok Yeo | |||
Haeng Jung Lee | |||
P2860 | cites work | Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model. | Q44836743 |
Tumor 3'-deoxy-3'-(18)F-fluorothymidine ((18)F-FLT) uptake by PET correlates with thymidine kinase 1 expression: static and kinetic analysis of (18)F-FLT PET studies in lung tumors | Q46104674 | ||
18F-FDG and 18F-FLT do not discriminate between reactive and metastatic lymph nodes in oral cancer. | Q46119190 | ||
The uptake of 3'-deoxy-3'-[18F]fluorothymidine into L5178Y tumours in vivo is dependent on thymidine kinase 1 protein levels | Q46404885 | ||
Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. | Q54117465 | ||
Structural modifications at the 2'- and 3'-positions of some pyrimidine nucleosides as determinants of their interaction with the mouse erythrocyte nucleoside transporter | Q70667382 | ||
Expression of thymidine phosphorylase as an indicator of poor prognosis for patients with transitional cell carcinoma of the bladder | Q73504286 | ||
Hallmarks of Cancer: The Next Generation | Q22252312 | ||
Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity | Q28114917 | ||
Comparisons of anti-human immunodeficiency virus activities, cellular transport, and plasma and intracellular pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-azido-3'-deoxythymidine | Q28318354 | ||
Diverging substrate specificity of pure human thymidine kinases 1 and 2 against antiviral dideoxynucleosides | Q28621379 | ||
Thymidine Phosphorylase/β-tubulin III expressions predict the response in Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel | Q33903541 | ||
Human thymidine kinase 1. Regulation in normal and malignant cells | Q34296535 | ||
The 5'-nucleotidases as regulators of nucleotide and drug metabolism | Q34427241 | ||
Etoposide increases equilibrative nucleoside transporter 1 activity and fluorothymidine uptake: screening of 60 cytotoxic agents | Q34509132 | ||
Different modes of transport for 3H-thymidine, 3H-FLT, and 3H-FMAU in proliferating and nonproliferating human tumor cells | Q36012091 | ||
PET imaging of cellular proliferation | Q36031444 | ||
Thymidine phosphorylase (platelet-derived endothelial-cell growth factor) in cancer biology and treatment | Q36057816 | ||
Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now? | Q36175746 | ||
Targeting platelet-derived endothelial cell growth factor/thymidine phosphorylase for cancer therapy | Q36850635 | ||
Imaging of cell proliferation: status and prospects | Q37181529 | ||
[(18)F]FLT: an imaging biomarker of tumour proliferation for assessment of tumour response to treatment. | Q37972435 | ||
Correlation between Ki-67 immunohistochemistry and 18F-fluorothymidine uptake in patients with cancer: A systematic review and meta-analysis. | Q38015605 | ||
Current molecular imaging positron emitting radiotracers in oncology | Q38217835 | ||
[(18)F]FLT-PET imaging does not always "light up" proliferating tumor cells | Q38435509 | ||
Induction of thymidine kinase 1 after 5-fluorouracil as a mechanism for 3'-deoxy-3'-[18F]fluorothymidine flare. | Q38482480 | ||
[18F]Fluorothymidine positron emission tomography before and 7 days after gefitinib treatment predicts response in patients with advanced adenocarcinoma of the lung | Q38497891 | ||
Radiolabeled uracil derivative as a novel SPECT probe for thymidine phosphorylase: suppressed accumulation into tumor cells by target gene knockdown | Q39470802 | ||
Biodistribution and uptake of 3'-deoxy-3'-fluorothymidine in ENT1-knockout mice and in an ENT1-knockdown tumor model | Q39665962 | ||
Evaluation of 5'-deoxy-5'-[F-18]fluorothymidine as a tracer of intracellular thymidine phosphorylase activity | Q40115491 | ||
Metabolism of 3'-deoxy-3'-[F-18]fluorothymidine in proliferating A549 cells: validations for positron emission tomography | Q40508408 | ||
Effect of p53 activation on cell growth, thymidine kinase-1 activity, and 3'-deoxy-3'fluorothymidine uptake | Q40565389 | ||
Monitoring tumor cell proliferation by targeting DNA synthetic processes with thymidine and thymidine analogs. | Q40609681 | ||
Cytosolic high K(m) 5'-nucleotidase and 5'(3')-deoxyribonucleotidase in substrate cycles involved in nucleotide metabolism | Q40842487 | ||
Thymidine concentrations in serum and urine of different animal species and man | Q41346695 | ||
The role of human nucleoside transporters in uptake of 3'-deoxy-3'-fluorothymidine | Q43650689 | ||
Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells. | Q44128080 | ||
Suppression of metastasis by thymidine phosphorylase inhibitor | Q44253163 | ||
P433 | issue | 7 | |
P921 | main subject | tipiracil | Q21098889 |
tipiracil hydrochloride | Q27162848 | ||
P1104 | number of pages | 9 | |
P304 | page(s) | 1327-1335 | |
P577 | publication date | 2014-02-22 | |
P1433 | published in | European Journal of Nuclear Medicine and Molecular Imaging | Q15708890 |
P1476 | title | Thymidine phosphorylase influences [(18)F]fluorothymidine uptake in cancer cells and patients with non-small cell lung cancer | |
P478 | volume | 41 |
Q47877900 | 3'-Deoxy-3'-[(18)F]Fluorothymidine Uptake Is Related to Thymidine Phosphorylase Expression in Various Experimental Tumor Models |
Q51169855 | Assessment of metabolism-dependent drug efficacy and toxicity on a multilayer organs-on-a-chip. |
Q60957206 | Enhanced Anticancer Activity of 5'-DFUR-PCL-MPEG Polymeric Prodrug Micelles Encapsulating Chemotherapeutic Drugs |
Q38312373 | Image-derived biomarkers and multimodal imaging strategies for lung cancer management |
Q38427767 | Positron emission tomography imaging of human colon cancer xenografts in mice with [18F]fluorothymidine after TAS-102 treatment |
Search more.